Search company, investor...

Urturn

urturn.com

Total Raised

$13.9M

Investors Count

Deal Terms

Funding, Valuation & Revenue

2 Fundings

Urturn has raised $13.9M over 2 rounds.

Urturn's latest funding round was a Series A for $13.4M on May 22, 2013.

Urturn's latest post-money valuation is from May 2013.

Date	Round	Amount	Investors	Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.	Revenue	Sources
5/22/2013	Series A	$13.4M	Balderton Capital, and Debiopharm Group	$99M	0 FY undefined	9
	Angel	$99M	Subscribe to see more	$99M	0 FY undefined	0

Date	5/22/2013
Round	Series A	Angel
Amount	$13.4M	$99M
Investors	Balderton Capital, and Debiopharm Group	Subscribe to see more
Valuation	$99M	$99M
Revenue	0 FY undefined	0 FY undefined
Sources	9	0

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.

Click Now. Join a live demo

Looking for a leg up on competitive, customer and technology insights?

CB Insights puts confidence and clarity into your most strategic decisions.

See how. Join a demo.

Trusted by the world's smartest companies to:

Predict emerging trends
See competitors' playbooks
Stalk the smart money
Identify tomorrow's challengers
Spot growing industries
Kill analyst data work

Let's see how we can help you!

Urturn Deal Terms

1 Deal Term

Urturn's deal structure is available for 1 funding round, including their Series A from May 22, 2013.

Round	Series A
Funding Date	$99M
Pre-Money Valuation
Post-Money Valuation
Amount Raised	$99M
Shares Authorized
Issuance Price
Dividend Rate
Liquidation Preferences
Liquidation Price
Participation
Conversion Price
Anti Dilution
General Voting	$99M
Board Voting	$99M
Par Value

Round	Funding Date	Pre-Money Valuation	Post-Money Valuation	Amount Raised	Shares Authorized	Issuance Price	Dividend Rate	Liquidation Preferences	Liquidation Price	Participation	Conversion Price	Anti Dilution	General Voting	Board Voting	Par Value
Series A	$99M			$99M									$99M	$99M

Urturn Investors

2 Investors

Urturn has 2 investors. Balderton Capital invested in Urturn's Series A funding round.

First funding	Last Funding	Investor	Rounds	Board Seats	Type	Location
5/22/2013	5/22/2013	Balderton Capital	1 Series A		Venture Capital	United Kingdom
00/00/0000	00/00/0000	Debiopharm Group	Subscribe to see more		Corporation	Switzerland

First funding	5/22/2013	00/00/0000
Last Funding	5/22/2013	00/00/0000
Investor	Balderton Capital	Debiopharm Group
Rounds	1 Series A	Subscribe to see more
Board Seats
Type	Venture Capital	Corporation
Location	United Kingdom	Switzerland